RSV IMMUNIZATION
Clinical trials for RSV IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new RSV IMMUNIZATION trials appear
Sign up with your email to follow new studies for RSV IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-dose antibody slashes RSV hospitalizations in infants
Prevention CompletedThis study tested a single injection of nirsevimab in over 8,000 healthy infants under 1 year old to see if it could prevent hospitalizations from RSV, a common respiratory virus. Babies received either the shot or no intervention and were followed for up to 6 months. The goal wa…
Matched conditions: RSV IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Czech RSV shot study: will parents protect their babies?
Knowledge-focused CompletedThis study will observe how many eligible infants in Czechia receive nirsevimab, a monoclonal antibody that helps prevent RSV, during their first RSV season. Researchers will survey parents of about 250 infants born between April 2025 and March 2027 to understand immunization rat…
Matched conditions: RSV IMMUNIZATION
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC